IE820075L - 4-amino-chloroquinolines - Google Patents
4-amino-chloroquinolinesInfo
- Publication number
- IE820075L IE820075L IE820075A IE7582A IE820075L IE 820075 L IE820075 L IE 820075L IE 820075 A IE820075 A IE 820075A IE 7582 A IE7582 A IE 7582A IE 820075 L IE820075 L IE 820075L
- Authority
- IE
- Ireland
- Prior art keywords
- amino
- formula
- image
- optionally substituted
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
4-Amino-chloroquinolines of the formula: <IMAGE> in which R1 represents a hydrogen atom or an alkyl radical (1 to 5 carbon atoms), and R2 represents an alkyl radical (1 to 5 carbon atoms) optionally substituted by a dialkylamino group, or a phenyl radical optionally substituted by one or more carboxy and hydroxy radicals and alkyl radicals (1 to 4 carbon atoms) optionally substituted by a dialkylamino group, are prepared by the condensation of an amine of the formula: <IMAGE> with a chloro-1,2,3,4-tetrahydroquinolin-4-one of the formula: <IMAGE> with aromatization of the tetrahydroquinoline, the reaction being carried out in the presence of a ruthenium based catalyst on a support. The 4-amino-chloroquinoline products are useful as pharmaceuticals.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8100765A FR2498187A1 (en) | 1981-01-16 | 1981-01-16 | PROCESS FOR THE PREPARATION OF AMINO-4 CHLORO-7 QUINOLINES |
Publications (2)
Publication Number | Publication Date |
---|---|
IE820075L true IE820075L (en) | 1982-07-16 |
IE51957B1 IE51957B1 (en) | 1987-04-29 |
Family
ID=9254223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE75/82A IE51957B1 (en) | 1981-01-16 | 1982-01-15 | Process for the preparation of 4-amino-chloroquinolines |
Country Status (13)
Country | Link |
---|---|
US (1) | US4421920A (en) |
EP (1) | EP0056766B1 (en) |
JP (1) | JPS57171973A (en) |
KR (1) | KR870001921B1 (en) |
AT (1) | ATE7492T1 (en) |
CA (1) | CA1171861A (en) |
DE (1) | DE3260150D1 (en) |
DK (1) | DK148805C (en) |
FR (1) | FR2498187A1 (en) |
HU (1) | HU184985B (en) |
IE (1) | IE51957B1 (en) |
IN (1) | IN158327B (en) |
ZA (1) | ZA82277B (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2892298A (en) * | 1957-08-05 | 1959-06-30 | Earl J Chaney | Pickup device |
GB8426584D0 (en) * | 1984-10-19 | 1984-11-28 | Beecham Group Plc | Compounds |
WO1986006718A1 (en) * | 1985-05-17 | 1986-11-20 | The Australian National University | Antimalarial compounds |
US4789678A (en) * | 1986-08-25 | 1988-12-06 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds |
CA1340821C (en) * | 1988-10-06 | 1999-11-16 | Nobuyuki Fukazawa | Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components |
PT100905A (en) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | BICYCLE HYGIENEOUS HETEROCYCLIC COMPOUNDS CONTAINING BENZENE, CYCLOHEXAN OR PYRIDINE AND PYRIMIDINE, PYRIDINE OR IMIDAZOLE SUBSTITUTES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
CA2133620A1 (en) * | 1993-10-28 | 1995-04-29 | Werner Hofheinz | Aminoquinoline derivatives |
AU6168296A (en) * | 1995-06-07 | 1996-12-30 | The Administrators Of The Tulane Eductional Fund | Chloroquine analogs and methods of preventing and treating p lasmodial disease |
CN1116286C (en) | 1996-03-05 | 2003-07-30 | 曾尼卡有限公司 | 4-anilinoquinazoline derivatives |
ATE300521T1 (en) * | 1996-09-25 | 2005-08-15 | Astrazeneca Ab | QUINOLINE DERIVATIVES THAT DELAY THE EFFECT OF GROWTH FACTORS LIKE VEGF |
GB9910579D0 (en) | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
GB9910580D0 (en) | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
US20040229908A1 (en) * | 1999-07-13 | 2004-11-18 | Jodi Nelson | Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias |
US6417177B1 (en) | 1999-07-13 | 2002-07-09 | Alpha Research Group, Llc | Chloroquine derivatives for the treatment of Parkinson's disease |
EP1274692B1 (en) * | 2000-04-07 | 2006-08-02 | AstraZeneca AB | Quinazoline compounds |
AU2002210714A1 (en) * | 2000-11-02 | 2002-06-11 | Astrazeneca Ab | Substituted quinolines as antitumor agents |
EP1337513A1 (en) * | 2000-11-02 | 2003-08-27 | AstraZeneca AB | 4-substituted quinolines as antitumor agents |
US7084157B2 (en) * | 2002-05-17 | 2006-08-01 | Rajeev Raut | Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation |
US20040002451A1 (en) * | 2002-06-20 | 2004-01-01 | Bruce Kerwin | Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing |
GB0215823D0 (en) * | 2002-07-09 | 2002-08-14 | Astrazeneca Ab | Quinazoline derivatives |
GB0225579D0 (en) * | 2002-11-02 | 2002-12-11 | Astrazeneca Ab | Chemical compounds |
US7108992B2 (en) * | 2002-11-27 | 2006-09-19 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
US6916627B2 (en) * | 2002-11-27 | 2005-07-12 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
CN1984660B (en) | 2003-07-03 | 2010-12-15 | 美瑞德生物工程公司 | 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis |
US8309562B2 (en) * | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
MXPA06007242A (en) * | 2003-12-23 | 2006-08-18 | Pfizer | Novel quinoline derivatives. |
ES2237332B1 (en) | 2004-01-14 | 2006-11-01 | Consejo Sup. Investig. Cientificas | DERIVATIVES OF PIRIDINIO AND QUINOLINIO. |
US8586613B2 (en) | 2004-01-14 | 2013-11-19 | Universidad De Granada | Pyridinium and quinolinium derivatives |
EP1833482A4 (en) | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | Compounds and therapeutical use thereof |
US8258145B2 (en) * | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
US8440695B2 (en) * | 2005-11-09 | 2013-05-14 | St Jude Children's Research Hospital | Use of chloroquine to treat metabolic syndrome |
CN105693606B (en) * | 2016-03-09 | 2017-12-05 | 西安科技大学 | A kind of method of asymmetric synthesis of optical voidness (R)/(S) HCQ |
CN105693605B (en) * | 2016-03-09 | 2017-12-22 | 西安科技大学 | A kind of method of asymmetric synthesis of optical voidness (R)/(S) chloroquine |
EP4251746A1 (en) | 2020-11-30 | 2023-10-04 | Cellectis SA | Use of aminoquinoline compounds for higher gene integration |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2653940A (en) * | 1951-01-27 | 1953-09-29 | William S Johnson | Process for preparing 4-quinolyl secondary amines |
-
1981
- 1981-01-16 FR FR8100765A patent/FR2498187A1/en active Granted
-
1982
- 1982-01-14 JP JP57003535A patent/JPS57171973A/en active Pending
- 1982-01-15 HU HU82121A patent/HU184985B/en not_active IP Right Cessation
- 1982-01-15 IE IE75/82A patent/IE51957B1/en unknown
- 1982-01-15 CA CA000394273A patent/CA1171861A/en not_active Expired
- 1982-01-15 KR KR8200161A patent/KR870001921B1/en active
- 1982-01-15 DE DE8282400080T patent/DE3260150D1/en not_active Expired
- 1982-01-15 EP EP82400080A patent/EP0056766B1/en not_active Expired
- 1982-01-15 DK DK16582A patent/DK148805C/en not_active IP Right Cessation
- 1982-01-15 US US06/339,722 patent/US4421920A/en not_active Expired - Fee Related
- 1982-01-15 IN IN36/DEL/82A patent/IN158327B/en unknown
- 1982-01-15 AT AT82400080T patent/ATE7492T1/en active
- 1982-01-15 ZA ZA82277A patent/ZA82277B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR830009038A (en) | 1983-12-17 |
IE51957B1 (en) | 1987-04-29 |
ZA82277B (en) | 1982-11-24 |
FR2498187A1 (en) | 1982-07-23 |
FR2498187B1 (en) | 1983-09-30 |
EP0056766A1 (en) | 1982-07-28 |
JPS57171973A (en) | 1982-10-22 |
ATE7492T1 (en) | 1984-06-15 |
DE3260150D1 (en) | 1984-06-20 |
HU184985B (en) | 1984-11-28 |
DK16582A (en) | 1982-07-17 |
DK148805C (en) | 1986-04-01 |
KR870001921B1 (en) | 1987-10-22 |
US4421920A (en) | 1983-12-20 |
CA1171861A (en) | 1984-07-31 |
EP0056766B1 (en) | 1984-05-16 |
IN158327B (en) | 1986-10-18 |
DK148805B (en) | 1985-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE820075L (en) | 4-amino-chloroquinolines | |
GR79637B (en) | ||
GB2185252B (en) | Triazole derivatives | |
ZA858169B (en) | New adamantanamine derivatives,processes for their preparation and drugs in which they are present | |
ES8101550A1 (en) | Pyrrolidine-2-methanol derivatives, process for their preparation and medicaments containing them. | |
IE822391L (en) | 4-acylamino-1-azaadamantanes | |
FR2498607B1 (en) | ||
ES481287A1 (en) | Esters of 1,5-dimethylbicyclo-[3,2,1]octan-8-ol | |
GB2078736B (en) | Indole and indoline derivatives | |
ES8204716A1 (en) | Benzylidene derivatives | |
ATE87307T1 (en) | ISOINDOLINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION. | |
ES8504139A1 (en) | Benzimidazole derivatives | |
IL65666A (en) | Derivatives of 4-aminomethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones and process for their preparation | |
EP0074497A3 (en) | Process for the preparation of 3-alkyl-6-methyl-beta-resorcylic-acid esters | |
IL65667A (en) | 4-(4-phenyl-1-piperidinyl)methyl-5-benzoyl-1,3-dihydro-2h-imidazol-2-one derivatives and process for their preparation | |
DE3160549D1 (en) | Process for the preparation of chlorophenols | |
ES8305732A1 (en) | Procedure for preparing imidazole derivatives. (Machine-translation by Google Translate, not legally binding) | |
IE792347L (en) | Benzimidazole derivatives. | |
ES8305333A1 (en) | Novel sulfimine compound |